Nicotine Lozenge Bioequivalence Study

• Status: Completed
• Trial end date: 2011-08-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare the bio equivalence of new nicotine lozenge formulation with the reference nicotine lozenge so as to deliver the same nicotine blood profile.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• Participants must be healthy smokers who usually smoked their first cigarette within 30 minutes of waking.

• Body Mass Index within the range 19-27 kilograms/meters^2

Exclusion Criteria:

• Participants who used chewing tobacco or tobacco products other than cigarettes within 21 days of screening visit